MIDOSTAURIN vs RYDAPT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Attribute	MIDOSTAURIN	RYDAPT
Rating	54/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	MIDOSTAURIN	MIDOSTAURIN
Manufacturer	Teva	Novartis
Dosage forms	Capsule	Capsule
Drug class	—	—
Boxed warning	None	None
Treats	Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis	Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis

midostaurin rydapt

Rating

54/100

70/100

Pharmacy pays

—

Type

Active ingredient

MIDOSTAURIN

Manufacturer

Teva

Novartis

Dosage forms

Capsule

Drug class

—

Boxed warning

None

Treats

Acute Myeloid Leukemia, Hematologic Neoplasms, Systemic Mastocytosis

Frequently asked questions

Which is better-rated, Midostaurin or Rydapt?

By our independent rating, Rydapt scores higher — 3.5 vs 2.7 out of 5 for Midostaurin. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Midostaurin and Rydapt?

Both Midostaurin and Rydapt share the active ingredient Midostaurin.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.